Our Leadership Team

Patrick van Berkel, PhD

Senior Vice President, Research & Development

Patrick van Berkel, PhD, is Senior Vice President of Research & Development at ADC Therapeutics.

Dr. van Berkel has more than 20 years of experience in the biotech industry, specializing in the development of antibody-based therapeutics.

Prior to joining ADC Therapeutics, Dr. van Berkel spent more than 9 years with Genmab in various roles, including Vice President of Antibody Technology and Vice President of CMC R&D.

Dr. van Berkel has a chemistry degree from the University of University of Nijmegen, The Netherlands (1991) and did his thesis at the University of Leiden, The Netherlands (1998).

Back to Our Leadership Team